Skip to main content
VSEE
NASDAQ Technology

VSee Health 2025 10-K：收入增长40%至1460万美元，仍报告每股亏损$(0.73)

feedReported by Wiseek News
Sentiment info
Negative
Importance info
8
Price
$0.245
Mkt Cap
$10.811M
52W Low
$0.193
52W High
$2.52
Market data snapshot near publication time

summarizeSummary

VSee Health 在其10-K 文件中报告了2025年的年度财务结果，显示出40%的同比收入增长，达到1462万美元，主要由iDoc收购和更高的远程医疗量驱动。尽管出现了显著的营业收入增长，但公司报告了每股基本和稀释亏损$(0.73)和净亏损$(1474)万美元。虽然由于没有商誉损害，净亏损比上一年有了明显改善，但公司仍然处于大量亏损状态。对于微型上市公司来说，即使有收入增长，持续的亏损也会引发关于长期可持续性和现金燃烧的担忧。交易者将会关注盈利的迹象或清晰的盈利路径，以及持续的收入增长势头。

在该公告发布时，VSEE的交易价格为$0.25，交易所为NASDAQ，所属行业为Technology，市值约为$1081.1万。 52周交易区间为$0.19至$2.52。 这则新闻被评估为消极市场情绪，重要性评分为8/10。 来源：Wiseek News。

show_chartPrice Chart

Share this article

Copied!

feed VSEE - Latest Insights

VSEE
Apr 01, 2026, 9:21 PM EDT
Filing Type: 424B3
Importance Score:
9
VSee Health Registers 33.8M Shares for Resale Amidst Going Concern Warning and Nasdaq Delisting Notice
Sentiment: Negative
View Wiseek Article
VSEE
Mar 31, 2026, 5:35 PM EDT
Source: Wiseek News
Importance Score:
8
VSee Health 2025 10-K: Revenue Up 40% to $14.6M, Still Reports $(0.73) Loss Per Share
Sentiment: Negative
View Wiseek Article
VSEE
Mar 31, 2026, 5:25 PM EDT
Filing Type: 10-K
Importance Score:
9
VSee Health Reports Going Concern Doubt, Material Weaknesses, and Nasdaq Delisting Threat Amidst Dilutive Financing
Sentiment: Negative
View Wiseek Article
VSEE
Mar 05, 2026, 6:01 AM EST
Filing Type: 424B3
Importance Score:
9
Stockholders Approve Issuance of 19.6M Shares for Warrants, Enabling Resale of 33.8M Shares
Sentiment: Negative
View Wiseek Article
VSEE
Feb 25, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
Director Converts $311K in Promissory Notes to Equity, Strengthening Balance Sheet
Sentiment: Positive
View Wiseek Article
VSEE
Feb 19, 2026, 5:15 PM EST
Filing Type: 8-K
Importance Score:
8
VSee Health Invests $2.0M for 10% Stake in GoMyRx, Enters Managed Services Agreement
Sentiment: Neutral
View Wiseek Article
VSEE
Feb 17, 2026, 5:25 PM EST
Filing Type: DEFA14A
Importance Score:
7
VSee Health Corrects Share Count and Beneficial Ownership Ahead of Special Meeting
Sentiment: Neutral
View Wiseek Article
VSEE
Feb 05, 2026, 10:15 AM EST
Filing Type: DEF 14A
Importance Score:
8
VSee Health Seeks Shareholder Approval for Highly Dilutive $6M Private Placement
Sentiment: Neutral
View Wiseek Article
VSEE
Jan 26, 2026, 5:11 PM EST
Filing Type: PRE 14A
Importance Score:
8
VSee Health Seeks Shareholder Approval for Highly Dilutive $6M Private Placement and Warrant Issuance
Sentiment: Neutral
View Wiseek Article
VSEE
Jan 08, 2026, 5:11 PM EST
Filing Type: 424B3
Importance Score:
9
VSee Health Registers 33.8 Million Shares for Resale, Signaling Substantial Dilution
Sentiment: Negative
View Wiseek Article